menu
    • menu

    Company profile for Akebia Therapeutics

    NEW Drugs in Dev: 5
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We were founded in 2007 to discover and develop therapeutic solutions leveraging the potential of hypoxia inducible factor—or HIF—biology. We believe HIF-Prolyl Hydroxylase (HIF-PH) inhibition could represent an approach to treating certain conditions where there is unmet need. Our objective is to develop and commercialize these products, starting with our lead compound, vadadustat, an investigational product being studied...
    We were founded in 2007 to discover and develop therapeutic solutions leveraging the potential of hypoxia inducible factor—or HIF—biology. We believe HIF-Prolyl Hydroxylase (HIF-PH) inhibition could represent an approach to treating certain conditions where there is unmet need. Our objective is to develop and commercialize these products, starting with our lead compound, vadadustat, an investigational product being studied in patients with anemia due to chronic kidney disease (CKD).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Akebia TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 First Street, Suite 1400 Cambridge, MA 02142
    Telephone
    Telephone
    +1 617-871-2098
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://akebia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akebia-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/akebiatx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akebia Therapeutics Grants Inducements Under Nasdaq Rule
    Akebia Therapeutics Grants Inducements Under Nasdaq Rule

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267835/37519/en/Akebia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Akebia Appoints Biopharmaceutical Leader Philip Vickers
    Akebia Appoints Biopharmaceutical Leader Philip Vickers

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266979/37519/en/Akebia-Therapeutics-Appoints-Biopharmaceutical-Leader-Philip-Vickers-Ph-D-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    Akebia Therapeutics Hosts Kidney R&D Day on April 2, 2026
    Akebia Therapeutics Hosts Kidney R&D Day on April 2, 2026

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259434/37519/en/Akebia-Therapeutics-to-Host-Virtual-R-D-Day-Highlighting-Robust-Kidney-Disease-Pipeline-on-April-2-2026.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Akebia Therapeutics at Leerink 2026 Global Healthcare Conference
    Akebia Therapeutics at Leerink 2026 Global Healthcare Conference

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248291/37519/en/Akebia-Therapeutics-to-Present-at-the-Leerink-Partners-2026-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Akebia Therapeutics Grants Inducements Per Nasdaq LR 5635(c)(4)
    Akebia Therapeutics Grants Inducements Per Nasdaq LR 5635(c)(4)

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247868/37519/en/Akebia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Akebia To Present Q4 & Full Year 2025 Financial Result
    Akebia To Present Q4 & Full Year 2025 Financial Result

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241017/37519/en/Akebia-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Discuss-Recent-Business-Highlights.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search